Correlation Between Neutrophil-to-lymphocyte Ratio with Gleason Score in Patients with Prostate Cancer at Adam Malik Hospital Medan 2013 - 2015
Affiliations
Context: A grading system was created by Donald F. Gleason for prostate cancer as prognostic indicators. The neutrophil-to-lymphocyte ratio (NLR) was found that it could be a prognostic factor in solid tumors.
Aims: This study aims to assess whether there is a correlation between NLR with the results of the Gleason score of patients with prostate adenocarcinoma biopsy at Haji Adam Malik Hospital Medan.
Settings And Design: A total of 121 patients underwent a prostate biopsy from early January 2013 to December 2015 at Adam Malik Hospital.
Subjects And Methods: Of the 121 patients, thirty were not included in the study because of incomplete baseline data and a history of hematological abnormalities. Data from 91 patients were then taken, including age, hematologic data prebiopsy, prostate-specific antigen (PSA) on initial examination, prostate weight estimation, and Gleason scores from biopsy results.
Statistical Analysis Used: The data are processed with SPSS version 22.
Results: A significant moderate strength correlation was found between NLR and Gleason Score ( = 0.572; = 0.001). However, no statistically significant correlation found between NLR and prostate weight estimation ( = 0.077; = 0.469) and NLR with PSA ( = 0.072; = 0.496).
Conclusions: A significant correlation between the neutrophil-to-lymphocyte ratio and the Gleason score was noted. Further studies are needed to confirm these findings.
Establishing a model predicting Gleason grade group upgrading in prostate cancer.
Chen J, Chen Q, Wang Z, Yan X, Wang Y, Zhang Y Transl Androl Urol. 2024; 13(8):1378-1387.
PMID: 39280670 PMC: 11399042. DOI: 10.21037/tau-24-155.
Wang H, Xie D, Wang S, Wu L, Chu Y, Yang P Cancer Rep (Hoboken). 2024; :e1977.
PMID: 38258491 PMC: 10849998. DOI: 10.1002/cnr2.1977.
Wang S, Ji Y, Ma J, Du P, Cao Y, Yang X Front Oncol. 2023; 12:1079622.
PMID: 36713540 PMC: 9878388. DOI: 10.3389/fonc.2022.1079622.